Trial intelligence / Profile preview

COPCOV prophylaxis study in healthcare workers

2020-001441-39Phase 3Unknown

Sponsor
University of Oxford
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Chloroquine prophylaxis, Hydroxychloroquine prophylaxis and Placebo (3 arms). Status: unknown.

02

Drugs

hydroxychloroquinechloroquine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2020-001441-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001441-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call